A detailed history of Evanson Asset Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Evanson Asset Management, LLC holds 23,444 shares of CORT stock, worth $894,154. This represents 0.06% of its overall portfolio holdings.

Number of Shares
23,444
Previous 23,444 -0.0%
Holding current value
$894,154
Previous $590,000 28.98%
% of portfolio
0.06%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$21.1 - $27.46 $159,516 - $207,597
-7,560 Reduced 24.38%
23,444 $590,000
Q4 2023

Jan 18, 2024

SELL
$24.82 - $32.88 $91,982 - $121,853
-3,706 Reduced 10.68%
31,004 $1.01 Million
Q3 2023

Oct 19, 2023

SELL
$21.97 - $33.8 $167,850 - $258,231
-7,640 Reduced 18.04%
34,710 $945,000
Q2 2023

Jul 10, 2023

BUY
$21.44 - $25.15 $54,672 - $64,132
2,550 Added 6.41%
42,350 $942,000
Q3 2017

Nov 14, 2017

BUY
$12.3 - $19.3 $489,540 - $768,140
39,800
39,800 $768,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.08B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Evanson Asset Management, LLC Portfolio

Follow Evanson Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evanson Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evanson Asset Management, LLC with notifications on news.